LEAD coalition urges Congress to hold hearing on Alzheimer's disease
On Sept. 23, AAGP joined other mental health organizations in sending a letter to congressional health care leaders to request a hearing on Alzheimer's disease and related disorders this fall. Led by the Leaders Engaged on Alzheimer's Disease coalition, the letter requests that the House Energy and Commerce Committee convene a hearing on the implementation of the National Plan to Address Alzheimer's Disease to determine the plan's effectiveness at "cutting through the red tape, incentivizing innovation, fostering collaboration and seizing every opportunity" to work towards the end of Alzheimer's disease and related disorders. Established by the National Alzheimer's Project Act in January 2011, the National Plan was created with the goal of overcoming Alzheimer's disease by 2025. The LEAD coalition is a diverse organization including patient advocacy and voluntary health nonprofits, philanthropies and foundations, trade and professional associations, academic research and clinical institutions, and biotechnology and pharmaceutical companies.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063